Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FRLN | AMGN | BMY | VRTX | GILD |
| Company | Freeline Therapeutics Holdings Plc Adss | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 6.49 | 275.81 | 58.57 | 454.72 | 92.59 |
| High | 6.49 | 279.16 | 58.79 | 462.02 | 92.60 |
| Low | 6.48 | 273.86 | 57.59 | 450.00 | 89.86 |
| Last | 6.48 | 278.92 | 58.31 | 459.21 | 91.48 |
| Change | unch | +0.60 | -0.38 | +2.24 | -1.01 |
| % Change | unch | +0.22% | -0.65% | +0.49% | -1.09% |
| Volume | 5,600 | 1,958,756 | 4,654,655 | 651,709 | 4,102,334 |
| 20-Day Average Volume | 9,370 | 4,444,042 | 11,271,473 | 1,364,278 | 7,370,088 |
| Previous Close | 6.48 | 278.32 | 58.69 | 456.97 | 92.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.43 | 293.67 | 57.96 | 472.98 | 92.02 |
| 20-Day Raw Stochastic | 92.31% | 29.23% | 62.66% | 18.66% | 42.51% |
| 20-Day Relative Strength | 59.63% | 33.99% | 58.26% | 44.95% | 55.20% |
| Weighted Alpha | +4.30 | -4.51 | +24.97 | +21.33 | +24.66 |
| Today's Opinion | 100% Buy | 72% Sell | 100% Buy | 8% Sell | 88% Buy |
| Previous Opinion | 100% Buy | 72% Sell | 100% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 02/09/24 | -0.58% since 11/26/24 | -0.54% since 11/26/24 | -1.73% since 11/26/24 | +0.20% since 11/26/24 |
| Low | 6.40 on 02/12/24 | 273.86 on 12/04/24 | 57.59 on 12/04/24 | 451.05 on 12/04/24 | 89.86 on 12/04/24 |
| High | 6.49 on 02/16/24 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 470.93 on 11/29/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | +1.09% since 01/16/24 | -12.15% since 11/04/24 | +5.37% since 11/04/24 | -2.92% since 11/04/24 | +1.88% since 11/04/24 |
| Low | 6.36 on 01/24/24 | 257.80 on 11/26/24 | 53.97 on 11/08/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 6.49 on 02/16/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +37.58% since 11/16/23 | -15.80% since 09/04/24 | +16.94% since 09/04/24 | -4.09% since 09/04/24 | +15.67% since 09/04/24 |
| Low | 4.63 on 11/17/23 | 257.80 on 11/26/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 77.74 on 09/05/24 |
| High | 6.55 on 12/05/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +65.73% since 08/16/23 | -9.43% since 06/04/24 | +39.94% since 06/04/24 | -3.36% since 06/04/24 | +42.66% since 06/04/24 |
| Low | 2.60 on 10/06/23 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 |
| High | 7.70 on 11/03/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,129 | 149,606,192 | 119,033,712 | 117,683,024 | 115,267,136 |
| Shares Outstanding, K | 4,341 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -88,970,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 10,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -12,090,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.66 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 12/01/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 04/02/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.47 | 51.23 | 0.00 | 21.22 |